Melanoma vaccine (Sanofi Genzyme)

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameMelanoma vaccine (Sanofi Genzyme)

Drug Alias NameAd2CMV-MART1Ad2CMV-gp100

ClassificationVaccines > Development/production technology > Dendritic cell vaccineCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy > Dendritic cell vaccineVaccines > Development/production technology > Recombinant vector vaccine

Mechanisms of ActionImmunostimulantsT lymphocytes stimulants

TargetsNot applicable

Therapy Area/IndicationsMelanoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesGenzyme Corp

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesGenzyme Corp

Active IndicationsN/A

Inactive IndicationsMelanoma

Other Information

ATC CodeN/A